Scrip Regulatory Affairs
European Commission jury still out over future legal framework for recast
13 May 2011
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU Commission proposes clinical evidence requirements for all IVDs except lowest-risk
- EU medtech regulatory reform could involve unannounced notified body visits, greater transparency and tighter controls on Class III devices
- EU parliament resolution plan expected to call for device pre-market authorisation system
- European Commission to propose leading role in new regulatory future for its expert devices group?
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
